Explore our featured stock ideas and investment opportunities to make informed decisions in today's market.
View AllLatest ARCH VENTURE CORP Stock Portfolio
$163Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About ARCH VENTURE CORP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $163.5 Millions as of 31 Dec, 2023.
The top stock holdings of ARCH Venture Management, LLC are RVMD, VERV, ERAS. The fund has invested 56.7% of it's portfolio in REVOLUTION MEDICINES, INC. and 17.1% of portfolio in VERVE THERAPEUTICS, INC.
The fund managers got completely rid off EQRX, INC. (EQRX) stocks. They significantly reduced their stock positions in DENALI THERAPEUTICS, INC. (DNLI). ARCH Venture Management, LLC opened new stock positions in REVOLUTION MEDICINES, INC. (RVMD).
The top stock holdings of ARCH Venture Management, LLC are RVMD, VERV, ERAS. The fund has invested 56.7% of it's portfolio in REVOLUTION MEDICINES, INC. and 17.1% of portfolio in VERVE THERAPEUTICS, INC.
The fund managers got completely rid off EQRX, INC. (EQRX) stocks. They significantly reduced their stock positions in DENALI THERAPEUTICS, INC. (DNLI). ARCH Venture Management, LLC opened new stock positions in REVOLUTION MEDICINES, INC. (RVMD).
New Buys
| Ticker | $ Bought |
|---|---|
| REVOLUTION MEDICINES, INC. | 92,736,500 |
New stocks bought by ARCH VENTURE CORP
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| DENALI THERAPEUTICS, INC. | -45.05 |
ARCH VENTURE CORP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| EQRX, INC. | -80,664,500 |
ARCH VENTURE CORP got rid off the above stocks
Current Stock Holdings of ARCH VENTURE CORP
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS, INC. | 5.00 | 381,249 | 8,181,600 | REDUCED | -45.05 | |
| EQRX | EQRX, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ERAS | ERASCA, INC. | 14.40 | 11,055,600 | 23,548,300 | UNCHANGED | 0.00 | |
| GOSS | GOSSAMER BIO, INC. | 4.50 | 8,055,920 | 7,351,020 | UNCHANGED | 0.00 | |
| OMIC | SINGULAR GENOMICS SYSTEMS, INC. | 1.07 | 3,798,930 | 1,747,890 | UNCHANGED | 0.00 | |
| RVMD | REVOLUTION MEDICINES, INC. | 56.72 | 3,233,490 | 92,736,500 | NEW | ||
| UBX | UNITY BIOTECHNOLOGY, INC. | 1.19 | 1,004,820 | 1,939,300 | UNCHANGED | 0.00 | |
| VERV | VERVE THERAPEUTICS, INC. | 17.13 | 2,008,810 | 28,002,800 | UNCHANGED | 0.00 |